4-(3-phenylphenyl)pyridine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(3-phenylphenyl)pyridine
• 英文别名: 4-([1,1'-Biphenyl]-3-yl)pyridine
• 化学式: C₁₇H₁₃N
• 分子量: 231.297
• InChiKey: BTCMLEQQKSXWBU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-(3-phenylphenyl)pyridine 、 vinylidene-1,1-diphosphonic acid 以 水 为溶剂， 反应 2.0h， 以68%的产率得到2-[4-(3-phenylphenyl)pyridinium-1-yl]ethylidene-1,1-bisphosphonic acid monosodium salt
  参考文献：
  名称：

  Activity of Nitrogen-Containing and Non-Nitrogen-Containing Bisphosphonates on Tumor Cell Lines

  摘要：

  We synthesized and tested three series of bisphosphonates for their activity in inhibiting the growth of three human tumor cell lines: MCF-7 (breast), NCI-H460 (lung), and SF-268 (CNS). The first series of compounds consisted of 49 nitrogen-containing bisphosphonates, the most active species being a tetrakispivaloyloxymethyl (POM) ester, having an (average) IC50 of 6.8 mu M. The second series of compounds consisted of nine terphenylbisphosphonates, the most active species also being a POM ester, having an IC50 of 2.2 mu M. The third series of compounds consisted of seven halogen or cyanophenylbisphosphonates, the most active species again being a POM ester, having an IC50 of 500 nM. Taken together, these results are of interest because they show that bisphosphonate esters can have potent activity against a variety of tumor cell lines, with the most active terphenyl-and halophenyl-containing species having IC50 values similar to 10-40x lower than the most potent commercially available bisphosphonates.

  DOI：

  10.1021/jm060280e
• 作为产物：
  描述：

  N-[3-(4-pyridinyl)phenyl]acetamide 在 phosphorus pentoxide 、 乙酸酐 、 亚硝酰氯 作用下， 生成 4-(3-phenylphenyl)pyridine
  参考文献：
  名称：

  Heilbron et al., Journal of the Chemical Society, 1940, p. 1279,1283

  摘要：

  DOI：

文献信息

• Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
  申请人：Zhou Ping

  公开号：US20070004730A1

  公开（公告）日：2007-01-04

  The present invention provides a 2-amino-5-heteroaryl-5-phenylimidazolone compound of formula I The present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles

  本发明提供了一种式I的2-氨基-5-杂环基-5-苯基咪唑酮化合物。本发明还提供了使用该化合物抑制β-分泌酶（BACE）和治疗β-淀粉样沉积和神经原纤维缠结的方法。
• AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR BETA-SECRETASE MODULATION
  申请人：Zhou Ping

  公开号：US20090042908A1

  公开（公告）日：2009-02-12

  The present invention provides a 2-amino-5-heteroaryl-5-phenylimidazolone compound of formula I The present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles

  本发明提供一种式为I的2-氨基-5-杂环基-5-苯基咪唑酮化合物。本发明还提供了使用该化合物的方法，以抑制β-分泌酶（BACE）并治疗β-淀粉样沉积和神经原纤维缠结。
• ORGANIC MATERIALS FOR OLEDS
  申请人：UNIVERSAL DISPLAY CORPORATION

  公开号：US20150207082A1

  公开（公告）日：2015-07-23

  A novel compound based on aza- and diazodibenzofurans; aza- and diaza dibenzothiophenes, such as benzothieno- and benzofuropyrimidines as well as benzothieno- and benzofuropyrazines useful for electron-transporting host material in green, red, yellow, and white phosphorescent emitting devices is disclosed.

  本发明揭示了一种基于氮杂二苯并呋喃和氮杂二苯并噻吩的新化合物；例如苯并噻吩和苯并呋吡啶以及苯并噻吩和苯并呋吡嗪，这些化合物可用作绿色、红色、黄色和白色磷光发射器件中的电子传输宿主材料。
• Construction of Heterobiaryl Skeletons through Pd-Catalyzed Cross-Coupling of Nitroarenes and Heterocyclic Arylborononate Esters with a Sterically Demanding NHC Ligand
  作者：Wei Chen、Wanzhi Chen、Miaochang Liu、Huayue Wu

  DOI：10.1021/acs.orglett.2c02796

  日期：2022.9.30

  cross-couplings of nitroarenes and heteroarylboronate esters has been developed. A number of heterobiaryl compounds containing pyridine, pyrimidine, quinoline, furan, thiophene, and pyrazole were prepared using [Pd(cinnamyl)Cl]2/2-aryl-5-(2,4,6-triisopropylphenyl)-2,3-imidazolylidene[1,5-a]pyridines as the catalysts in good to excellent yields. The synthetic practicality of this approach is demonstrated through

  已经开发了钯催化的硝基芳烃和杂芳基硼酸酯的 Suzuki-Miyaura 交叉偶联。使用[Pd(肉桂基)Cl] 2 /2-芳基-5-(2,4,6-三异丙基苯基)-2,3-制备了许多含有吡啶、嘧啶、喹啉、呋喃、噻吩和吡唑的杂二芳基化合物咪唑亚基[1,5- a ]吡啶作为催化剂，收率良好。这种方法的合成实用性通过类药物分子的合成得到证明。
• Modular Access to <i>meta</i>-Substituted Benzenes via Mo-Catalyzed Intermolecular Deoxygenative Benzene Formation
  作者：Yi-Zhe Yu、Jin Bai、Jia-Min Peng、Jia-Sheng Yao、Chun-Xiang Zhuo

  DOI：10.1021/jacs.3c01330

  日期：——

  The substituted benzene derivatives are essential to organic synthesis, medicinal chemistry, and material science. However, the 1,3-di- and 1,3,5-trisubstituted benzenes are far less prevalent in small-molecule drugs than other substitution patterns, likely due to the lack of robust, efficient, and convenient synthetic methods. Here, we report a Mo-catalyzed intermolecular deoxygenative benzene-forming

  取代苯衍生物对有机合成、药物化学和材料科学至关重要。然而，1,3-二-和 1,3,5-三取代苯在小分子药物中的普遍性远低于其他取代模式，这可能是由于缺乏稳健、高效和方便的合成方法。在这里，我们报告了一种 Mo 催化的分子间脱氧苯形成反应，该反应是现成的炔酮和烯丙基胺的反应。通过使用市售的钼催化剂，以高达 88% 的收率获得了多种不对称和未官能化的 1,3-二和 1,3,5-三取代苯。通过生物活性分子的合成转化、放大合成和衍生化进一步说明了该方法的合成潜力。初步的机理研究表明，这种苯形成过程可能通过钼催化的氮杂迈克尔加成/[1,5]-氢化物转移/环化/芳构化级联进行。该策略不仅为各种间位取代的苯衍生物，但也证明了钼催化在具有挑战性的分子间脱氧交叉偶联反应中的潜力。